"The share repurchase program does not obligate PharmaCyte to acquire a specific dollar amount or number of shares and may be extended, modified, or discontinued at any time."
No one trusts the CEO of PMCB.with the announcement of a possible stock repurchase of up to 10 million dollars, the price is up only .01 at this point.
Market Data 
Markets 
AI
